Founded in Zaragoza (Spain) in 2012. It is a Spanish biotechnological company focused on researching, developing, manufacturing and commercializing CE-IVD products and bioinformatic solutions for results interpretation. The portfolio is divided in two different product lines, based on two different molecular technologies: Real Time PCR (qPCR) and fragment analysis. qPCR line offers kits for HLA-disease (HLA-B27, HLA Behçet Disease, HLA CELIAC, HLA CELIAC Plus, HLA-A29, HLA-DQB106:02), pharmacogenetics (HLA-B57:01, HLA-C06), food intolerances (lactose intolerance) and haematological panels (hemochromatosis and thrombophilia). The product line based on fragment analysis is focused on rare disease diagnostics (X Fragile syndrome, Huntington disease, Friedreich´s Ataxia, Myotonic Dystrophy, Spinocerebellar Ataxias).